This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
UNPUBLISHED DATA ON FILE
To our knowledge, the materials used in the production of INVEGA SUSTENNA®, INVEGA TRINZA®, and INVEGA HAFYERA® syringe components (also referred to as packaging materials) do not contain latex/synthetic rubber as an ingredient; however, we cannot guarantee that the materials do not come in contact with latex/synthetic rubber during the manufacturing or packaging process (e.g. latex gloves).1,2
PUBLISHED LITERATURE
A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, and DERWENT Drug File (and/or other resources, including internal/external databases) pertaining to this topic was conducted on 29 April 2025.
| 1 | Data on File. INVEGA SUSTENNA (paliperidone palmitate) - Patient Safety and Compliance Information of Excipients (EXC) and Immediate Containers (IMC); 2024. |
| 2 | Data on File. INVEGA TRINZA/TREVICTA/HAFYERA/BYANNLI (paliperidone palmitate) - Patient Safety and Compliance Information of Excipients (EXC) and Immediate Containers (IMC); 2024. |
